Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
32.71 CHF | +1.36% | +2.44% | +19.25% |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+19.25% | 15.33B | |
+21.43% | 44.15B | |
+23.03% | 23.02B | |
+12.42% | 13.74B | |
+50.13% | 12.16B | |
-10.02% | 6.84B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.88% | 5.66B | |
+7.89% | 4.85B |
- Stock Market
- Equities
- SDZ Stock
- News Sandoz Group AG
- Sandoz Group Settles Patent Disputes with Amgen